How Tapinarof Cream 1% is Set to Revolutionize Psoriasis Care
Last week, the US Food and Drug Administration approved tapinarof cream, 1% (VTAMA) for the treatment of plaque psoriasis of all severities in adult patients, ushering in the first and only FDA-approved steroid-free topical medication in its class.
Remarkably, it had been 25 years since a novel chemical entity had been introduced into psoriasis care from a brand-new mechanism of action, and from the data gathered from the phase 3 PSOARING 1 and 2 trials as well as the long term extension (LTE) study, it couldn’t have come at a better time.
Pivotal phase 3 data showed treatment with tapinarof…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.